Sự tăng cường biểu hiện của Parkin trong các tế bào tiền thân thần kinh từ bệnh nhân mắc bệnh Parkinson đã dịch chuyển transcriptome hướng tới trạng thái bình thường

Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ (2012) The role of autophagy in Parkinson’s disease. Cold Spring Harb Perspect Med 2(4):a009357. https://doi.org/10.1101/cshperspect.a009357 Oosterveen T, Garção P, Moles-Garcia E, Soleilhavoup C, Travaglio M, Sheraz S, Peltrini R, Patrick K et al (2021) Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson’s disease. Stem Cell Reports 16(11):2718–2735. https://doi.org/10.1016/j.stemcr.2021.09.014 Coppedè F (2012) Genetics and epigenetics of Parkinson’s disease. SciWorldJ 2012:489830. https://doi.org/10.1100/2012/489830 Chu YT, Tai CH, Lin CH, Wu RM (2021) Updates on the genetics of Parkinson’s disease: clinical implications and future treatment. Acta Neurol Taiwan 30(3):83–93 Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605–608. https://doi.org/10.1038/33416 Wang XL, Feng ST, Wang ZZ, Yuan YH, Chen NH, Zhang Y (2021) Parkin, an E3 ubiquitin ligase, plays an essential role in mitochondrial quality control in Parkinson’s disease. Cell Mol Neurobiol 41(7):1395–1411. https://doi.org/10.1007/s10571-020-00914-2 Kamienieva I, Duszyński J, Szczepanowska J (2021) Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease. Transl Neurodegener 10(1):5. https://doi.org/10.1186/s40035-020-00229-8 Joch M, Ase AR, Chen CX, MacDonald PA, Kontogiannea M, Corera AT, Brice A, Séguéla P et al (2007) Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Mol Biol Cell 18(8):3105–3118. https://doi.org/10.1091/mbc.e05-11-1027 Kumar A, Aguirre JD, Condos TE, Martinez-Torres RJ, Chaugule VK, Toth R, Sundaramoorthy R, Mercier P et al (2015) Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. EMBO J 34(20):2506–2521. https://doi.org/10.15252/embj.201592337 Moskal N, Riccio V, Bashkurov M, Taddese R, Datti A, Lewis PN, Angus McQuibban G (2020) ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway. Nat Commun 11(1):88. https://doi.org/10.1038/s41467-019-13781-3 Kramer ER (2015) The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system. Neural Regen Res 10(11):1752–1753. https://doi.org/10.4103/1673-5374.165295 Cakir Z, Funk K, Lauterwasser J, Todt F, Zerbes RM, Oelgeklaus A, Tanaka A, van der Laan M et al (2017) Parkin promotes proteasomal degradation of misregulated BAX. J Cell Sci 130(17):2903–2913. https://doi.org/10.1242/jcs.200162 Zhang X, Lin C, Song J, Chen H, Chen X, Ren L, Zhou Z, Pan J et al (2019) Parkin facilitates proteasome inhibitor-induced apoptosis via suppression of NF-κB activity in hepatocellular carcinoma. Cell Death Dis 10(10):719. https://doi.org/10.1038/s41419-019-1881-x Yoshii SR, Kishi C, Ishihara N, Mizushima N (2011) Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 286(22):19630–19640. https://doi.org/10.1074/jbc.M110.209338 Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, Youle RJ (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191(7):1367–1380. https://doi.org/10.1083/jcb.201007013 Bendikov-Bar I, Rapaport D, Larisch S, Horowitz M (2014) Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS. Orphanet J Rare Dis 9:86. https://doi.org/10.1186/1750-1172-9-86 Kemeny S, Dery D, Loboda Y, Rovner M, Lev T, Zuri D, Finberg JP, Larisch S (2012) Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein. PLoS One 7(7):e38837. https://doi.org/10.1371/journal.pone.0038837 Khandelwal PJ, Moussa CE (2010) The relationship between Parkin and protein aggregation in neurodegenerative diseases. Front Psychiatry 1:15. https://doi.org/10.3389/fpsyt.2010.00015 Yasuda T, Miyachi S, Kitagawa R, Wada K, Nihira T, Ren YR, Hirai Y, Ageyama N et al (2007) Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates. Neuroscience 144(2):743–753. https://doi.org/10.1016/j.neuroscience.2006.09.052 Chung E, Choi Y, Park J, Nah W, Park J, Jung Y, Lee J, Lee H et al (2020) Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein. Sci Adv 6(18):eaba1193. https://doi.org/10.1126/sciadv.aba1193 Chopra R, Kalaiarasan P, Ali S, Srivastava AK, Aggarwal S, Garg VK, Bhattacharya SN, Bamezai RN (2014) PARK2 and proinflammatory/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population. BMJ Open 4(2):e004239. https://doi.org/10.1136/bmjopen-2013-004239 Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C et al (2007) Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci 27(8):1868–1878. https://doi.org/10.1523/JNEUROSCI.5537-06.2007 Sha D, Chin LS, Li L (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19(2):352–363. https://doi.org/10.1093/hmg/ddp501 Frank-Cannon TC, Tran T, Ruhn KA, Martinez TN, Hong J, Marvin M, Hartley M, Treviño I et al (2008) Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci 28(43):10825–10834. https://doi.org/10.1523/JNEUROSCI.3001-08.2008 Connor-Robson N, Booth H, Martin JG, Gao B, Li K, Doig N, Vowles J, Browne C et al (2019) An integrated transcriptomics and proteomics analysis reveals functional endocytic dysregulation caused by mutations in LRRK2. Neurobiol Dis 127:512–526. https://doi.org/10.1016/j.nbd.2019.04.005 Zambon F, Cherubini M, Fernandes HJR, Lang C, Ryan BJ, Volpato V, Bengoa-Vergniory N, Vingill S et al (2019) Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons. Hum Mol Genet 28(12):2001–2013. https://doi.org/10.1093/hmg/ddz038 Chang KH, Huang CY, Ou-Yang CH, Ho CH, Lin HY, Hsu CL, Chen YT, Chou YC et al (2021) In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation. Stem Cell Res Ther 12(1):508. https://doi.org/10.1186/s13287-021-02585-2 Okarmus J, Havelund JF, Ryding M, Schmidt SI, Bogetofte H, Heon-Roberts R, Wade-Martins R, Cowley SA et al (2021) Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: altered mitochondrial and energy metabolism. Stem Cell Rep 16(6):1510–1526. https://doi.org/10.1016/j.stemcr.2021.04.022 Kumar M, Acevedo-Cintrón J, Jhaldiyal A, Wang H, Andrabi SA, Eacker S, Karuppagounder SS, Brahmachari S et al (2020) Defects in mitochondrial biogenesis drive mitochondrial alterations in PARKIN-deficient human dopamine neurons. Stem Cell Rep 15(3):629–645. https://doi.org/10.1016/j.stemcr.2020.07.013 Kuzumaki N, Suda Y, Iwasawa C, Narita M, Sone T, Watanabe M, Maekawa A, Matsumoto T et al (2019) Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson’s disease. Brain 142(6):1675–1689. https://doi.org/10.1093/brain/awz084 Bogetofte H, Jensen P, Ryding M, Schmidt SI, Okarmus J, Ritter L, Worm CS, Hohnholt MC et al (2019) PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons. Front Cell Neurosci 13:297. https://doi.org/10.3389/fncel.2019.00297 Chung SY, Kishinevsky S, Mazzulli JR, Graziotto J, Mrejeru A, Mosharov EV, Puspita L, Valiulahi P et al (2016) Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and α-synuclein accumulation. Stem Cell Rep 7(4):664–677. https://doi.org/10.1016/j.stemcr.2016.08.012 Aboud AA, Tidball AM, Kumar KK, Neely MD, Han B, Ess KC, Hong CC, Erikson KM et al (2015) PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper. Neurobiol Dis 73:204–212. https://doi.org/10.1016/j.nbd.2014.10.002 Vlasov IN, Alieva AK, Novosadova EV, Arsenyeva EL, Rosinskaya AV, Partevian SA, Grivennikov IA, Shadrina MI (2021) Transcriptome analysis of induced pluripotent stem cells and neuronal progenitor cells, derived from discordant monozygotic twins with Parkinson’s disease. Cells 10(12):3478. https://doi.org/10.3390/cells10123478 Novosadova EV, Nenasheva VV, Makarova IV, Dolotov OV, Inozemtseva LS, Arsenyeva EL, Chernyshenko SV, Sultanov RI et al (2020) Parkinson’s disease-associated changes in the expression of neurotrophic factors and their receptors upon neuronal differentiation of human induced pluripotent stem cells. J Mol Neurosci 70(4):514–521. https://doi.org/10.1007/s12031-019-01450-5 Nekrasov ED, Lebedeva OS, Chestkov IV, Syusina MA, Fedotova EYu, Lagarkova MA, Kiselev SL, Grivennikov IA et al (2011) Obtaining and characteristics of human induced pluripotent stem cells from skin fibroblasts of patients with neurodegenerative diseases. Cell Transplant Tissue Eng 6(4):82–88 Holmqvist S, Lehtonen S, Chumarina M, Puttonen KA, Azevedo C, Lebedeva O, Ruponen M, Oksanen M et al (2016) Creation of a library of induced pluripotent stem cells from Parkinsonian patients. NPJ Parkinsons Dis 2:16009. https://doi.org/10.1038/npjparkd.2016.9 Novosadova EV, Nekrasov ED, Chestkov IV, Surdina AV, Vasina AM, Bogomazova AN, Manuilova ES, Arsenyeva EL et al (2016) A platform for studying molecular and cellular mechanisms of Parkinson’s disease based on human induced pluripotent stem cells. Sovremennye Tehnologii v Med 8:157–166. https://doi.org/10.17691/stm2016.8.4.20 Nekrasov ED, Vigont VA, Klyushnikov SA, Lebedeva OS, Vassina EM, Bogomazova AN, Chestkov IV, Semashko TA et al (2016) Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons. Mol Neurodegener 11:27. https://doi.org/10.1186/s13024-016-0092-5 Lebedeva OS, Novosadova EV, Manuilova ES, Arsenyeva EL, Kiselev SL, Lagarkova MA, Khaspekov LG, Illarioshkin SN, Grivennikov IA (2014) Generation and characterization of a cellular model of Parkinson’s disease based on induced pluripotent stem cells. In: Tkachuk VA (ed.) Stem cells and regenerative medicine. MAKS press, Moscow Novosadova E, Anufrieva K, Kazantseva E, Arsenyeva E, Fedoseyeva V, Stepanenko E, Poberezhniy D, Illarioshkin S et al (2022) Transcriptome datasets of neural progenitors and neurons differentiated from induced pluripotent stem cells of healthy donors and Parkinson’s disease patients with mutations in the PARK2 gene. Data Brief 41:107958. https://doi.org/10.1016/j.dib.2022.107958 Shuvalova LD, Eremeev AV, Bogomazova AN, Novosadova EV, Zerkalenkova EA, Olshanskaya YV, Fedotova EY, Glagoleva ES et al (2020) Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson’s disease with deletion of the exon 2 in PARK2 gene. Stem Cell Res 44:101733. https://doi.org/10.1016/j.scr.2020.101733 Walker JM (1994) The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32:5–8. https://doi.org/10.1385/0-89603-268-X:5 Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15):2114–2120. https://doi.org/10.1093/bioinformatics/btu170 Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 14(4):417–419. https://doi.org/10.1038/nmeth.4197 Soneson C, Love MI, Robinson MD (2015) Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4:1521. https://doi.org/10.12688/f1000research.7563.2 Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https://doi.org/10.1186/s13059-014-0550-8 R Core Team (2021) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/ Wickham H (2016) ggplot2: elegant graphics for data analysis. Springer-Verlag, New York Kolde R (2019) pheatmap: pretty heatmaps. R package version 1.0.12. https://CRAN.R-project.org/package=pheatmap Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, Vilo J (2019) g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res 47(W1):W191–W198. https://doi.org/10.1093/nar/gkz369 Supek F, Bošnjak M, Škunca N, Šmuc T (2011) REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One 6(7):e21800. https://doi.org/10.1371/journal.pone.0021800 Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504. https://doi.org/10.1101/gr.1239303 Schulte C, Gasser T (2011) Genetic basis of Parkinson’s disease: inheritance, penetrance, and expression. Appl Clin Genet 4:67–80. https://doi.org/10.2147/TACG.S11639 Gil-Prieto R, Pascual-Garcia R, San-Roman-Montero J, Martinez-Martin P, Castrodeza-Sanz J, Gil-de-Miguel A (2016) Measuring the burden of hospitalization in patients with Parkinson’s disease in Spain. PLoS One 11(3):e0151563. https://doi.org/10.1371/journal.pone.0151563 Xu K, Alnaji N, Zhao J, Bertoni JM, Chen LW, Bhatti D, Qu M (2018) Comorbid conditions in Parkinson’s disease: a population-based study of statewide Parkinson’s disease registry. Neuroepidemiology 50(1–2):7–17. https://doi.org/10.1159/000484410 Koyano F, Yamano K, Kosako H, Tanaka K, Matsuda N (2019) Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL. J Biol Chem 294(26):10300–10314. https://doi.org/10.1074/jbc.RA118.006302 Xing S, Pan N, Xu W, Zhang J, Li J, Dang C, Liu G, Pei Z et al (2019) EphrinB2 activation enhances angiogenesis, reduces amyloid-β deposits and secondary damage in thalamus at the early stage after cortical infarction in hypertensive rats. J Cereb Blood Flow Metab 39(9):1776–1789. https://doi.org/10.1177/0271678X18769188 Zhong S, Pei D, Shi L, Cui Y, Hong Z (2019) Ephrin-B2 inhibits Aβ25-35-induced apoptosis by alleviating endoplasmic reticulum stress and promoting autophagy in HT22 cells. Neurosci Lett 704:50–56. https://doi.org/10.1016/j.neulet.2019.03.028 Islam F, Gopalan V, Lam AK (2018) RETREG1 (FAM134B): a new player in human diseases: 15 years after the discovery in cancer. J Cell Physiol 233(6):4479–4489. https://doi.org/10.1002/jcp.26384 Prevot TD, Sumitomo A, Tomoda T, Knutson DE, Li G, Mondal P, Banasr M, Cook JM et al (2021) Reversal of age-related neuronal atrophy by α5-GABAA receptor positive allosteric modulation. Cereb Cortex 31(2):1395–1408. https://doi.org/10.1093/cercor/bhaa310 Hokama M, Oka S, Leon J, Ninomiya T, Honda H, Sasaki K, Iwaki T, Ohara T et al (2014) Altered expression of diabetes-related genes in Alzheimer’s disease brains: the Hisayama study. Cereb Cortex 24(9):2476–2488. https://doi.org/10.1093/cercor/bht101 Qin L, Shu L, Zhong J, Pan H, Guo J, Sun Q, Yan X, Tang B et al (2019) Association of HIF1A and Parkinson’s disease in a Han Chinese population demonstrated by molecular inversion probe analysis. Neurol Sci 40(9):1927–1931. https://doi.org/10.1007/s10072-019-03905-4 Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277(31):27975–27981. https://doi.org/10.1074/jbc.M204152200 Liu J, Zhang C, Zhao Y, Yue X, Wu H, Huang S, Chen J, Tomsky K et al (2017) Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression. Nat Commun 8(1):1823. https://doi.org/10.1038/s41467-017-01947-w Mo J, Chen J, Zhang B (2020) Critical roles of FAM134B in ER-phagy and diseases. Cell Death Dis 11(11):983. https://doi.org/10.1038/s41419-020-03195-1 Xing L, Son JH, Stevenson TJ, Lillesaar C, Bally-Cuif L, Dahl T, Bonkowsky JL (2015) A serotonin circuit acts as an environmental sensor to mediate midline axon crossing through EphrinB2. J Neurosci 35(44):14794–14808. https://doi.org/10.1523/JNEUROSCI.1295-15.2015 Wimmer VC, Harty RC, Richards KL, Phillips AM, Miyazaki H, Nukina N, Petrou S (2015) Sodium channel β1 subunit localizes to axon initial segments of excitatory and inhibitory neurons and shows regional heterogeneity in mouse brain. J Comp Neurol 523(5):814–830. https://doi.org/10.1002/cne.23715 Bedogni F, Hodge RD, Elsen GE, Nelson BR, Daza RA, Beyer RP, Bammler TK, Rubenstein JL et al (2010) Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex. Proc Natl Acad Sci U S A 107(29):13129–13134. https://doi.org/10.1073/pnas.1002285107 Chung CY, Licznerski P, Alavian KN, Simeone A, Lin Z, Martin E, Vance J, Isacson O (2010) The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons. Brain 133(Pt 7):2022–2031. https://doi.org/10.1093/brain/awq142 Blazejewski SM, Bennison SA, Liu X, Toyo-Oka K (2021) High-throughput kinase inhibitor screening reveals roles for Aurora and Nuak kinases in neurite initiation and dendritic branching. Sci Rep 11(1):8156. https://doi.org/10.1038/s41598-021-87521-3 Beck HN, Drahushuk K, Jacoby DB, Higgins D, Lein PJ (2001) Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. BMC Neurosci 2:12. https://doi.org/10.1186/1471-2202-2-12 Cuenca-Bermejo L, Almela P, Navarro-Zaragoza J, Fernández Villalba E, González-Cuello A-M, Laorden M-L, Herrero M-T (2021) Cardiac changes in Parkinson’s disease: lessons from clinical and experimental evidence. Int J Mol Sci 22(24):13488. https://doi.org/10.3390/ijms222413488 Hong CT, Chan L, Wu D, Chen WT, Chien LN (2019) Association between Parkinson’s disease and atrial fibrillation: a population-based study. Front Neurol 10:22. https://doi.org/10.3389/fneur.2019.00022 Freyermuth F, Rau F, Kokunai Y et al (2016) Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat Commun 7:11067. https://doi.org/10.1038/ncomms11067 Pasquetti E, Lo Bianco M, Sullo F, Patanè F, Sciuto L, Polizzi A, Praticò A, Zanghì A et al (2021) SCN1B gene: a close relative to SCN1A. J Ped Neurol. https://doi.org/10.1055/s-0041-1727268 Brackenbury WJ, Isom LL (2011) Na channel β subunits: overachievers of the ion channel family. Front Pharmacol 2:53. https://doi.org/10.3389/fphar.2011.00053 Lin X, O’Malley H, Chen C, Auerbach D, Foster M, Shekhar A, Zhang M, Coetzee W et al (2015) Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts. J Physiol 593(6):1389–1407. https://doi.org/10.1113/jphysiol.2014.277699 Ablinger C, Geisler SM, Stanika RI, Klein CT, Obermair GJ (2020) Neuronal α2δ proteins and brain disorders. Pflugers Arch 472(7):845–863. https://doi.org/10.1007/s00424-020-02420-2 Cataldo S, Annoni GA, Marziliano N (2015) The perfect storm? Histiocytoid cardiomyopathy and compound CACNA2D1 and RANGRF mutation in a baby. Cardiol Young 25(1):174–176. https://doi.org/10.1017/S1047951113002382 Ramanan VK, Saykin AJ (2013) Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am J Neurodegener Dis 2(3):145–175 Dolma S, Selvadurai HJ, Lan X, Lee L, Kushida M, Voisin V, Whetstone H, So M et al (2016) Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells. Cancer Cell 29(6):859–873. https://doi.org/10.1016/j.ccell.2016.05.002 Wang Q, Dong X, Lu J, Hu T, Pei G (2020) Constitutive activity of a G protein-coupled receptor, DRD1, contributes to human cerebral organoid formation. Stem Cells 38(5):653–665. https://doi.org/10.1002/stem.3156 Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K et al (2012) Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun 3:668. https://doi.org/10.1038/ncomms1669 Jiang H, Jiang Q, Feng J (2004) Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J Biol Chem 279(52):54380–54386. https://doi.org/10.1074/jbc.M409282200 Peeler JC, Schedin-Weiss S, Soula M, Kazmi MA, Sakmar TP (2017) Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4. J Biol Chem 292(52):21623–21630. https://doi.org/10.1074/jbc.M116.758961 Skieterska K, Rondou P, Van Craenenbroeck K (2016) Dopamine D4 receptor ubiquitination. Biochem Soc Trans 44(2):601–605. https://doi.org/10.1042/BST20150281 Juyal RC, Das M, Punia S, Behari M, Nainwal G, Singh S, Swaminath PV, Govindappa ST et al (2006) Genetic susceptibility to Parkinson’s disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker. Neurogenetics 7:223–229. https://doi.org/10.1007/s10048-006-0048-y Dipanwita S, Arindam B, Atanu B, Kunal R, Jharna R (2022) Genetic polymorphisms in DRD4 and risk for Parkinson’s disease among Eastern Indians. Neurol India 70(2):729–732. https://doi.org/10.4103/0028-3886.344670 Fernández-Santiago R, Carballo-Carbajal I, Castellano G, Torrent R, Richaud Y, Sánchez-Danés A, Vilarrasa-Blasi R, Sánchez-Pla A et al (2015) Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson’s disease patients. EMBO Mol Med 7(12):1529–1546. https://doi.org/10.15252/emmm.201505439